Skip to main content

Table 4 Stage distribution among cancer cases eligible for survival analysis, Estonia, 1995–2006

From: Sex differences in cancer survival in Estonia: a population-based study

   No. of cases (%)  
Cancer site Extent Men Women p-value*
Mouth, pharynx All 1395 (100) 451 (100) p < 0.001
  Localized 564 (40) 256 (57)  
  Local/regional spread 752 (54) 169 (37)  
  Distant 57 (4) 19 (4)  
  Unknown 22 (2) 7 (2)  
Stomach All 2897 (100) 2412 (100) p < 0.001
  Localized 650 (22) 616 (26)  
  Local/regional spread 739 (26) 579 (24)  
  Distant 1404 (48) 1090 (45)  
  Unknown 104 (4) 127 (5)  
Colon All 1974 (100) 2712 (100) p = 0.048
  Localized 787 (40) 1039 (38)  
  Local/regional spread 509 (26) 748 (28)  
  Distant 625 (32) 819 (30)  
  Unknown 53 (3) 106 (4)  
Rectum All 1603 (100) 1582 (100) p = 0.099
  Localized 681 (42) 637 (40)  
  Local/regional spread 449 (28) 479 (30)  
  Distant 432 (27) 407 (26)  
  Unknown 41 (3) 59 (4)  
Pancreas All 1142 (100) 1035 (100) p = 0.114
  Localized 117 (10) 132 (13)  
  Local/regional spread 271 (24) 245 (24)  
  Distant 684 (60) 580 (56)  
  Unknown 70 (6) 78 (7)  
Lung All 6948 (100) 1647 (100) p = 0.003
  Localized 1127 (16) 285 (17)  
  Local/regional spread 2676 (39) 567 (34)  
  Distant 2846 (41) 699 (42)  
  Unknown 299 (4) 96 (6)  
Skin melanoma All 533 (100) 972 (100) p < 0.001
  Localized 360 (68) 761 (78)  
  Local/regional spread 98 (18) 108 (11)  
  Distant 60 (11) 74 (8)  
  Unknown 15 (3) 29 (3)  
Kidney All 1617 (100) 1193 (100) p < 0.001
  Localized 876 (54) 728 (61)  
  Local/regional spread 228 (14) 145 (12)  
  Distant 473 (29) 272 (23)  
  Unknown 40 (3) 48 (4)  
Bladder All 1760 (100) 659 (100) p = 0.299
  Localized 1325 (75) 486 (74)  
  Local/regional spread 213 (12) 87 (13)  
  Distant 152 (9) 50 (8)  
  Unknown 70 (4) 36 (5)  
  1. *Chi-squared test.